Report Detail
Global Intravenous Immune Globulin Therapies Market Growth (Status and Outlook) 2019-2024
- RnM3154763 |
- 20 March, 2019 |
- Global |
- 115 Pages |
- LPI(LP Information) |
- Other
Immune globulin derived from the plasma of paid and volunteer donors is used in the treatment of an array of disorders, including primary and secondary immune deficiency states and a variety of autoimmune and inflammatory disorders.
According to this study, over the next five years the Intravenous Immune Globulin Therapies market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Intravenous Immune Globulin Therapies business, shared in Chapter 3.
This report presents a comprehensive overview, market shares and growth opportunities of Intravenous Immune Globulin Therapies market by product type, application, key companies and key regions.
This study considers the Intravenous Immune Globulin Therapies value generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.
Liquid Form
Lyophilized Powder Form
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.
Immunodeficiency
Autoimmune Disease
Acute Infection
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Baxter
Grifols
CSL Plasma
Octapharma
Biotest
Kedrion
Kamada
China Biologic Products Holdings
Hualan Biological Engineering
Sichuan Yuanda Shuyang Pharmaceutical
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Intravenous Immune Globulin Therapies market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Intravenous Immune Globulin Therapies market by identifying its various subsegments.
Focuses on the key global Intravenous Immune Globulin Therapies players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Intravenous Immune Globulin Therapies with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Intravenous Immune Globulin Therapies submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global Intravenous Immune Globulin Therapies Market Report (Status and Outlook)
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Intravenous Immune Globulin Therapies Market Size 2014-2024
- 2.1.2 Intravenous Immune Globulin Therapies Market Size CAGR by Region
- 2.2 Intravenous Immune Globulin Therapies Segment by Type
- 2.2.1 Liquid Form
- 2.2.2 Lyophilized Powder Form
- 2.3 Intravenous Immune Globulin Therapies Market Size by Type
- 2.3.1 Global Intravenous Immune Globulin Therapies Market Size Market Share by Type (2014-2019)
- 2.3.2 Global Intravenous Immune Globulin Therapies Market Size Growth Rate by Type (2014-2019)
- 2.4 Intravenous Immune Globulin Therapies Segment by Application
- 2.4.1 Immunodeficiency
- 2.4.2 Autoimmune Disease
- 2.4.3 Acute Infection
- 2.5 Intravenous Immune Globulin Therapies Market Size by Application
- 2.5.1 Global Intravenous Immune Globulin Therapies Market Size Market Share by Application (2014-2019)
- 2.5.2 Global Intravenous Immune Globulin Therapies Market Size Growth Rate by Application (2014-2019)
3 Global Intravenous Immune Globulin Therapies by Players
- 3.1 Global Intravenous Immune Globulin Therapies Market Size Market Share by Players
- 3.1.1 Global Intravenous Immune Globulin Therapies Market Size by Players (2017-2019)
- 3.1.2 Global Intravenous Immune Globulin Therapies Market Size Market Share by Players (2017-2019)
- 3.2 Global Intravenous Immune Globulin Therapies Key Players Head office and Products Offered
- 3.3 Market Concentration Rate Analysis
- 3.3.1 Competition Landscape Analysis
- 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.4 New Products and Potential Entrants
- 3.5 Mergers & Acquisitions, Expansion
4 Intravenous Immune Globulin Therapies by Regions
- 4.1 Intravenous Immune Globulin Therapies Market Size by Regions
- 4.2 Americas Intravenous Immune Globulin Therapies Market Size Growth
- 4.3 APAC Intravenous Immune Globulin Therapies Market Size Growth
- 4.4 Europe Intravenous Immune Globulin Therapies Market Size Growth
- 4.5 Middle East & Africa Intravenous Immune Globulin Therapies Market Size Growth
5 Americas
- 5.1 Americas Intravenous Immune Globulin Therapies Market Size by Countries
- 5.2 Americas Intravenous Immune Globulin Therapies Market Size by Type
- 5.3 Americas Intravenous Immune Globulin Therapies Market Size by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Intravenous Immune Globulin Therapies Market Size by Countries
- 6.2 APAC Intravenous Immune Globulin Therapies Market Size by Type
- 6.3 APAC Intravenous Immune Globulin Therapies Market Size by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Intravenous Immune Globulin Therapies by Countries
- 7.2 Europe Intravenous Immune Globulin Therapies Market Size by Type
- 7.3 Europe Intravenous Immune Globulin Therapies Market Size by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Intravenous Immune Globulin Therapies by Countries
- 8.2 Middle East & Africa Intravenous Immune Globulin Therapies Market Size by Type
- 8.3 Middle East & Africa Intravenous Immune Globulin Therapies Market Size by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Global Intravenous Immune Globulin Therapies Market Forecast
- 10.1 Global Intravenous Immune Globulin Therapies Market Size Forecast (2019-2024)
- 10.2 Global Intravenous Immune Globulin Therapies Forecast by Regions
- 10.2.1 Global Intravenous Immune Globulin Therapies Forecast by Regions (2019-2024)
- 10.2.2 Americas Market Forecast
- 10.2.3 APAC Market Forecast
- 10.2.4 Europe Market Forecast
- 10.2.5 Middle East & Africa Market Forecast
- 10.3 Americas Forecast by Countries
- 10.3.1 United States Market Forecast
- 10.3.2 Canada Market Forecast
- 10.3.3 Mexico Market Forecast
- 10.3.4 Brazil Market Forecast
- 10.4 APAC Forecast by Countries
- 10.4.1 China Market Forecast
- 10.4.2 Japan Market Forecast
- 10.4.3 Korea Market Forecast
- 10.4.4 Southeast Asia Market Forecast
- 10.4.5 India Market Forecast
- 10.4.6 Australia Market Forecast
- 10.5 Europe Forecast by Countries
- 10.5.1 Germany Market Forecast
- 10.5.2 France Market Forecast
- 10.5.3 UK Market Forecast
- 10.5.4 Italy Market Forecast
- 10.5.5 Russia Market Forecast
- 10.5.6 Spain Market Forecast
- 10.6 Middle East & Africa Forecast by Countries
- 10.6.1 Egypt Market Forecast
- 10.6.2 South Africa Market Forecast
- 10.6.3 Israel Market Forecast
- 10.6.4 Turkey Market Forecast
- 10.6.5 GCC Countries Market Forecast
- 10.7 Global Intravenous Immune Globulin Therapies Forecast by Type
- 10.8 Global Intravenous Immune Globulin Therapies Forecast by Application
11 Key Players Analysis
- 11.1 Baxter
- 11.1.1 Company Details
- 11.1.2 Intravenous Immune Globulin Therapies Product Offered
- 11.1.3 Baxter Intravenous Immune Globulin Therapies Revenue, Gross Margin and Market Share (2017-2019)
- 11.1.4 Main Business Overview
- 11.1.5 Baxter News
- 11.2 Grifols
- 11.2.1 Company Details
- 11.2.2 Intravenous Immune Globulin Therapies Product Offered
- 11.2.3 Grifols Intravenous Immune Globulin Therapies Revenue, Gross Margin and Market Share (2017-2019)
- 11.2.4 Main Business Overview
- 11.2.5 Grifols News
- 11.3 CSL Plasma
- 11.3.1 Company Details
- 11.3.2 Intravenous Immune Globulin Therapies Product Offered
- 11.3.3 CSL Plasma Intravenous Immune Globulin Therapies Revenue, Gross Margin and Market Share (2017-2019)
- 11.3.4 Main Business Overview
- 11.3.5 CSL Plasma News
- 11.4 Octapharma
- 11.4.1 Company Details
- 11.4.2 Intravenous Immune Globulin Therapies Product Offered
- 11.4.3 Octapharma Intravenous Immune Globulin Therapies Revenue, Gross Margin and Market Share (2017-2019)
- 11.4.4 Main Business Overview
- 11.4.5 Octapharma News
- 11.5 Biotest
- 11.5.1 Company Details
- 11.5.2 Intravenous Immune Globulin Therapies Product Offered
- 11.5.3 Biotest Intravenous Immune Globulin Therapies Revenue, Gross Margin and Market Share (2017-2019)
- 11.5.4 Main Business Overview
- 11.5.5 Biotest News
- 11.6 Kedrion
- 11.6.1 Company Details
- 11.6.2 Intravenous Immune Globulin Therapies Product Offered
- 11.6.3 Kedrion Intravenous Immune Globulin Therapies Revenue, Gross Margin and Market Share (2017-2019)
- 11.6.4 Main Business Overview
- 11.6.5 Kedrion News
- 11.7 Kamada
- 11.7.1 Company Details
- 11.7.2 Intravenous Immune Globulin Therapies Product Offered
- 11.7.3 Kamada Intravenous Immune Globulin Therapies Revenue, Gross Margin and Market Share (2017-2019)
- 11.7.4 Main Business Overview
- 11.7.5 Kamada News
- 11.8 China Biologic Products Holdings
- 11.8.1 Company Details
- 11.8.2 Intravenous Immune Globulin Therapies Product Offered
- 11.8.3 China Biologic Products Holdings Intravenous Immune Globulin Therapies Revenue, Gross Margin and Market Share (2017-2019)
- 11.8.4 Main Business Overview
- 11.8.5 China Biologic Products Holdings News
- 11.9 Hualan Biological Engineering
- 11.9.1 Company Details
- 11.9.2 Intravenous Immune Globulin Therapies Product Offered
- 11.9.3 Hualan Biological Engineering Intravenous Immune Globulin Therapies Revenue, Gross Margin and Market Share (2017-2019)
- 11.9.4 Main Business Overview
- 11.9.5 Hualan Biological Engineering News
- 11.10 Sichuan Yuanda Shuyang Pharmaceutical
- 11.10.1 Company Details
- 11.10.2 Intravenous Immune Globulin Therapies Product Offered
- 11.10.3 Sichuan Yuanda Shuyang Pharmaceutical Intravenous Immune Globulin Therapies Revenue, Gross Margin and Market Share (2017-2019)
- 11.10.4 Main Business Overview
- 11.10.5 Sichuan Yuanda Shuyang Pharmaceutical News
12 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Intravenous Immune Globulin Therapies . Industry analysis & Market Report on Intravenous Immune Globulin Therapies is a syndicated market report, published as Global Intravenous Immune Globulin Therapies Market Growth (Status and Outlook) 2019-2024. It is complete Research Study and Industry Analysis of Intravenous Immune Globulin Therapies market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
